congenital-adrenal-hyperplasia

Documents about congenital-adrenal-hyperplasia

• Linear Growth of Children With Congenital Adrenal Hyperplasia#847470ClinicalTrials.gov
• Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia#889584ClinicalTrials.gov
• Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia#1113671ClinicalTrials.gov
• Dexamethasone Treatment of Congenital Adrenal Hyperplasia#1383026ClinicalTrials.gov
• Effects of Pioglitazone in Congenital Adrenal Hyperplasia#802857ClinicalTrials.gov
• Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia#1420348ClinicalTrials.gov
• A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia#856005ClinicalTrials.gov
• A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)#855066ClinicalTrials.gov
• Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia#1463870ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia#805606ClinicalTrials.gov
• An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia#1139212ClinicalTrials.gov
• Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia#1101076ClinicalTrials.gov
• Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023#185694IRIS
• Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets#886861ClinicalTrials.gov
• Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)#1161905ClinicalTrials.gov
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBIP-01435 in Adult Participants With Classic Congenital Adrenal Hyperplasia (CAH)#1282075ClinicalTrials.gov
• Questionnaire Study to Assess the Outcomes of the Management of Congenital Adrenal Hyperplasia Individuals#1475540ClinicalTrials.gov
• A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia#1350778ClinicalTrials.gov
• Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia#146353ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia#832215ClinicalTrials.gov
• Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency#1307246ClinicalTrials.gov
• A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)#812694ClinicalTrials.gov
• Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia#1010541ClinicalTrials.gov
• A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])#898318ClinicalTrials.gov
• Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia#876711ClinicalTrials.gov
• Fertility And Sexual Function In CAH: CALLIOPE#1125023ClinicalTrials.gov
• Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia#1228253ClinicalTrials.gov
• Gene Polymorphisms Influencing Steroid Synthesis and Action#1351097ClinicalTrials.gov
• China Adrenal Disease Registry#891926ClinicalTrials.gov
• Diffusion MRI features of acute encephalopathy due to stopping steroid medication abruptly in congentila adrenal hyperplasia#954811Koc University Digital Collections
• Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia#850699ClinicalTrials.gov
• Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia#1138508ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old#1150440ClinicalTrials.gov
• A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia#1058938ClinicalTrials.gov
• A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)#828751ClinicalTrials.gov
• Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy#28517ClinicalTrials.gov
• A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH#1309343ClinicalTrials.gov
• Continuous subcutaneous hydrocortisone infusion in pediatric primary adrenal insufficiency: a cohort study#156345HAL (France)
• A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH#1321511ClinicalTrials.gov
• Evaluation of Circadian Hormonal Balance: LC-MS/MS Measurement of Salivary and Serum Steroids in Patients With Congenital Adrenal Hyperplasia#1294441ClinicalTrials.gov
• Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH#1293511ClinicalTrials.gov
• Prenatal Dex Study#1486798ClinicalTrials.gov
• A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations#842385ClinicalTrials.gov
• Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) cohort#672691Spiral
• Updates in Prevalence, Diagnoses and Management of Adrenal Insufficiency in Saudi Arabia: A Comprehensive Review#384646HAL (France)
• Tweens to Teens Project at Penn State#1437208ClinicalTrials.gov
• Examining Genetic Differences Among People With 21-Hydroxylase Deficiency#911639ClinicalTrials.gov
• Factors affecting the quality of life of adults living with congenital adrenal hyperplasia: a qualitative study of lived experience.#214164NCBI PubMed Central
• Monogenic disorders of adrenal steroidogenesis#483818Spiral
• Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency#383642ClinicalTrials.gov